Interstitial Pneumonia Market, Global Outlook and Forecast 2022-2028

February 2022 | 62 pages | ID: I15A80DD0515EN
Market Monitor Global

Abstracts

Interstitial pneumonia is a disease in which the mesh-like walls of the alveoli become inflamed. The pleura (a thin covering that protects and cushions the lungs and the individual lobes of the lungs) might become inflamed as well. Interstitial Pneumonia treatment market in this report.

This report contains market size and forecasts of Interstitial Pneumonia in Global, including the following market information:

Global Interstitial Pneumonia Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Interstitial Pneumonia market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Usual Interstitial Pneumonitis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Interstitial Pneumonia include Boehringer Ingelheim, Bellerophon Therapeutics, Inc, Bayer, Fujirebio (Miraca), Philips and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Interstitial Pneumonia companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Interstitial Pneumonia Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Interstitial Pneumonia Market Segment Percentages, by Type, 2021 (%)

• Usual Interstitial Pneumonitis
• Nonspecific Interstitial Pneumonitis
• Desquamative Interstitial Pneumonitis
• Others

Global Interstitial Pneumonia Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Interstitial Pneumonia Market Segment Percentages, by Application, 2021 (%)

• Adults
• Children

Global Interstitial Pneumonia Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Interstitial Pneumonia Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Interstitial Pneumonia revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Interstitial Pneumonia revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Boehringer Ingelheim
• Bellerophon Therapeutics, Inc
• Bayer
• Fujirebio (Miraca)
• Philips
• Merck

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Interstitial Pneumonia Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Interstitial Pneumonia Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INTERSTITIAL PNEUMONIA OVERALL MARKET SIZE

2.1 Global Interstitial Pneumonia Market Size: 2021 VS 2028
2.2 Global Interstitial Pneumonia Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Interstitial Pneumonia Players in Global Market
3.2 Top Global Interstitial Pneumonia Companies Ranked by Revenue
3.3 Global Interstitial Pneumonia Revenue by Companies
3.4 Top 3 and Top 5 Interstitial Pneumonia Companies in Global Market, by Revenue in 2021
3.5 Global Companies Interstitial Pneumonia Product Type
3.6 Tier 1, Tier 2 and Tier 3 Interstitial Pneumonia Players in Global Market
  3.6.1 List of Global Tier 1 Interstitial Pneumonia Companies
  3.6.2 List of Global Tier 2 and Tier 3 Interstitial Pneumonia Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Interstitial Pneumonia Market Size Markets, 2021 & 2028
  4.1.2 Usual Interstitial Pneumonitis
  4.1.3 Nonspecific Interstitial Pneumonitis
  4.1.4 Desquamative Interstitial Pneumonitis
  4.1.5 Others
4.2 By Type - Global Interstitial Pneumonia Revenue & Forecasts
  4.2.1 By Type - Global Interstitial Pneumonia Revenue, 2017-2022
  4.2.2 By Type - Global Interstitial Pneumonia Revenue, 2023-2028
  4.2.3 By Type - Global Interstitial Pneumonia Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Interstitial Pneumonia Market Size, 2021 & 2028
  5.1.2 Adults
  5.1.3 Children
5.2 By Application - Global Interstitial Pneumonia Revenue & Forecasts
  5.2.1 By Application - Global Interstitial Pneumonia Revenue, 2017-2022
  5.2.2 By Application - Global Interstitial Pneumonia Revenue, 2023-2028
  5.2.3 By Application - Global Interstitial Pneumonia Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Interstitial Pneumonia Market Size, 2021 & 2028
6.2 By Region - Global Interstitial Pneumonia Revenue & Forecasts
  6.2.1 By Region - Global Interstitial Pneumonia Revenue, 2017-2022
  6.2.2 By Region - Global Interstitial Pneumonia Revenue, 2023-2028
  6.2.3 By Region - Global Interstitial Pneumonia Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Interstitial Pneumonia Revenue, 2017-2028
  6.3.2 US Interstitial Pneumonia Market Size, 2017-2028
  6.3.3 Canada Interstitial Pneumonia Market Size, 2017-2028
  6.3.4 Mexico Interstitial Pneumonia Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Interstitial Pneumonia Revenue, 2017-2028
  6.4.2 Germany Interstitial Pneumonia Market Size, 2017-2028
  6.4.3 France Interstitial Pneumonia Market Size, 2017-2028
  6.4.4 U.K. Interstitial Pneumonia Market Size, 2017-2028
  6.4.5 Italy Interstitial Pneumonia Market Size, 2017-2028
  6.4.6 Russia Interstitial Pneumonia Market Size, 2017-2028
  6.4.7 Nordic Countries Interstitial Pneumonia Market Size, 2017-2028
  6.4.8 Benelux Interstitial Pneumonia Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Interstitial Pneumonia Revenue, 2017-2028
  6.5.2 China Interstitial Pneumonia Market Size, 2017-2028
  6.5.3 Japan Interstitial Pneumonia Market Size, 2017-2028
  6.5.4 South Korea Interstitial Pneumonia Market Size, 2017-2028
  6.5.5 Southeast Asia Interstitial Pneumonia Market Size, 2017-2028
  6.5.6 India Interstitial Pneumonia Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Interstitial Pneumonia Revenue, 2017-2028
  6.6.2 Brazil Interstitial Pneumonia Market Size, 2017-2028
  6.6.3 Argentina Interstitial Pneumonia Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Interstitial Pneumonia Revenue, 2017-2028
  6.7.2 Turkey Interstitial Pneumonia Market Size, 2017-2028
  6.7.3 Israel Interstitial Pneumonia Market Size, 2017-2028
  6.7.4 Saudi Arabia Interstitial Pneumonia Market Size, 2017-2028
  6.7.5 UAE Interstitial Pneumonia Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Boehringer Ingelheim
  7.1.1 Boehringer Ingelheim Corporate Summary
  7.1.2 Boehringer Ingelheim Business Overview
  7.1.3 Boehringer Ingelheim Interstitial Pneumonia Major Product Offerings
  7.1.4 Boehringer Ingelheim Interstitial Pneumonia Revenue in Global Market (2017-2022)
  7.1.5 Boehringer Ingelheim Key News
7.2 Bellerophon Therapeutics, Inc
  7.2.1 Bellerophon Therapeutics, Inc Corporate Summary
  7.2.2 Bellerophon Therapeutics, Inc Business Overview
  7.2.3 Bellerophon Therapeutics, Inc Interstitial Pneumonia Major Product Offerings
  7.2.4 Bellerophon Therapeutics, Inc Interstitial Pneumonia Revenue in Global Market (2017-2022)
  7.2.5 Bellerophon Therapeutics, Inc Key News
7.3 Bayer
  7.3.1 Bayer Corporate Summary
  7.3.2 Bayer Business Overview
  7.3.3 Bayer Interstitial Pneumonia Major Product Offerings
  7.3.4 Bayer Interstitial Pneumonia Revenue in Global Market (2017-2022)
  7.3.5 Bayer Key News
7.4 Fujirebio (Miraca)
  7.4.1 Fujirebio (Miraca) Corporate Summary
  7.4.2 Fujirebio (Miraca) Business Overview
  7.4.3 Fujirebio (Miraca) Interstitial Pneumonia Major Product Offerings
  7.4.4 Fujirebio (Miraca) Interstitial Pneumonia Revenue in Global Market (2017-2022)
  7.4.5 Fujirebio (Miraca) Key News
7.5 Philips
  7.5.1 Philips Corporate Summary
  7.5.2 Philips Business Overview
  7.5.3 Philips Interstitial Pneumonia Major Product Offerings
  7.5.4 Philips Interstitial Pneumonia Revenue in Global Market (2017-2022)
  7.5.5 Philips Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck Interstitial Pneumonia Major Product Offerings
  7.6.4 Merck Interstitial Pneumonia Revenue in Global Market (2017-2022)
  7.6.5 Merck Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Interstitial Pneumonia Market Opportunities & Trends in Global Market
Table 2. Interstitial Pneumonia Market Drivers in Global Market
Table 3. Interstitial Pneumonia Market Restraints in Global Market
Table 4. Key Players of Interstitial Pneumonia in Global Market
Table 5. Top Interstitial Pneumonia Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Interstitial Pneumonia Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Interstitial Pneumonia Revenue Share by Companies, 2017-2022
Table 8. Global Companies Interstitial Pneumonia Product Type
Table 9. List of Global Tier 1 Interstitial Pneumonia Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Interstitial Pneumonia Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Interstitial Pneumonia Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Interstitial Pneumonia Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Interstitial Pneumonia Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Interstitial Pneumonia Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Interstitial Pneumonia Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Interstitial Pneumonia Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Interstitial Pneumonia Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Interstitial Pneumonia Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Interstitial Pneumonia Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Interstitial Pneumonia Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Interstitial Pneumonia Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Interstitial Pneumonia Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Interstitial Pneumonia Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Interstitial Pneumonia Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Interstitial Pneumonia Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Interstitial Pneumonia Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Interstitial Pneumonia Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Interstitial Pneumonia Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Interstitial Pneumonia Revenue, (US$, Mn), 2023-2028
Table 30. Boehringer Ingelheim Corporate Summary
Table 31. Boehringer Ingelheim Interstitial Pneumonia Product Offerings
Table 32. Boehringer Ingelheim Interstitial Pneumonia Revenue (US$, Mn), (2017-2022)
Table 33. Bellerophon Therapeutics, Inc Corporate Summary
Table 34. Bellerophon Therapeutics, Inc Interstitial Pneumonia Product Offerings
Table 35. Bellerophon Therapeutics, Inc Interstitial Pneumonia Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Corporate Summary
Table 37. Bayer Interstitial Pneumonia Product Offerings
Table 38. Bayer Interstitial Pneumonia Revenue (US$, Mn), (2017-2022)
Table 39. Fujirebio (Miraca) Corporate Summary
Table 40. Fujirebio (Miraca) Interstitial Pneumonia Product Offerings
Table 41. Fujirebio (Miraca) Interstitial Pneumonia Revenue (US$, Mn), (2017-2022)
Table 42. Philips Corporate Summary
Table 43. Philips Interstitial Pneumonia Product Offerings
Table 44. Philips Interstitial Pneumonia Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Interstitial Pneumonia Product Offerings
Table 47. Merck Interstitial Pneumonia Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Interstitial Pneumonia Segment by Type in 2021
Figure 2. Interstitial Pneumonia Segment by Application in 2021
Figure 3. Global Interstitial Pneumonia Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Interstitial Pneumonia Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Interstitial Pneumonia Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Interstitial Pneumonia Revenue in 2021
Figure 8. By Type - Global Interstitial Pneumonia Revenue Market Share, 2017-2028
Figure 9. By Application - Global Interstitial Pneumonia Revenue Market Share, 2017-2028
Figure 10. By Region - Global Interstitial Pneumonia Revenue Market Share, 2017-2028
Figure 11. By Country - North America Interstitial Pneumonia Revenue Market Share, 2017-2028
Figure 12. US Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Interstitial Pneumonia Revenue Market Share, 2017-2028
Figure 16. Germany Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 17. France Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Interstitial Pneumonia Revenue Market Share, 2017-2028
Figure 24. China Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 28. India Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Interstitial Pneumonia Revenue Market Share, 2017-2028
Figure 30. Brazil Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Interstitial Pneumonia Revenue Market Share, 2017-2028
Figure 33. Turkey Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Interstitial Pneumonia Revenue, (US$, Mn), 2017-2028
Figure 37. Boehringer Ingelheim Interstitial Pneumonia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bellerophon Therapeutics, Inc Interstitial Pneumonia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Interstitial Pneumonia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Fujirebio (Miraca) Interstitial Pneumonia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Philips Interstitial Pneumonia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Interstitial Pneumonia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)